According to a new case report oral THC is associated with symptom mitigation and reduced prescription drug use in a patient with severe Alzheimer’s-induced dementia. The case report was published in the journal Frontiers in Psychiatry and is titled Cannabinoid as beneficial replacement therapy for psychotropics to treat psychiatric symptoms in severe Alzheimer’s dementia: A clinical case report.
Those who consume marijuana through inhalation for extended periods of time are likely to report reductions in migraine frequency. This is according to a study published in the journal Brain Sciences, and first reported on by NORML. The measure was also published online by the U.S. National Institute of Health.
According to a new study, hemp-derived CBD oil extract is associated with improved HDL cholesterol levels. The study was published in Journal of Dietary Supplements: It’s titled Effects of hemp extract on markers of wellness, stress resilience, recovery and clinical biomarkers of safety in overweight, but otherwise healthy subjects.
For the study researchers examined the health effects of CBD extract (15 mg per serving) from hemp and compared it against a placebo. Researchers “determined the effects of a commercially available, GRAS (Generally Recognized As Safe) by independent conclusion, CBD-containing hemp oil extract on stress resilience, perceived recovery, mood, affect, body composition, and clinical safety markers in healthy human subjects.”
Support for expanding Arkansas’ limited medical marijuana program is supported by more than two out of every three voters in the state, according to new polling.
As reported on by local station ABC7, a new Talk Business & Politics-Hendrix College Poll of likely statewide voters shows the issue has gained momentum since its passage with 53% support in November 2016. In a survey conducted June 9-10, 2020, voters voiced a double-digit increase in approval.
Cannabinoids “consistently produced antinociceptive effects in preclinical models”, according to a new study being published by the European Journal of Pain: It was epublished by the United States National Institute of Health. It’s titled Current Evidence of Cannabinoid-Based Analgesia Obtained in Preclinical and Human Experimental Settings.
“Cannabinoids have a long record of recreational and medical use and become increasingly approved for pain therapy”, states the study’s abstract. “This development is based on preclinical and human experimental research summarized in this review. Cannabinoid CB1 receptors are widely expressed throughout the nociceptive system.”
A new study has found that medical marijuana reduces the use of prescription drugs in nursing homes. The study is titled Will medical cannabis treatment reduce pharmaceutical residues in the aquatic environment? A case study from an elderly nursing home, and was published in the journal Advances in Health and Behavior.
Recent exposure to marijuana is not associated with an increased risk of ischemic stroke. This is according to a new study published in the journal Neurology: Clinical Practice. The study is titled Association between recent cannabinoid use and acute ischemic stroke.
For the study researchers with the University of Mississippi, Department of Neurology examined whether or not those testing positive for marijuana during a hospital admission screen were more likely to suffer from an acute ischemic stroke as compared to those who tested negative. According to NORML, who first reported on the study, researchers identified no link between recent cannabis exposure and either an increased or decreased risk of stroke after adjusting for confounders such as age, high blood pressure, and high cholesterol.
According to a new study published by the Journal of Dietary Supplements, many cannabinoid (CBD)-infused products that are purchased over-the-counter contain far lower percentages of cannabidiol than advertised on the products’ labeling. The study, titled Content versus label claims in cannabidiol (CBD) products obtained from commercial outlets in the state of Mississippi, was first reported on by NORML.
According to a new study “cannabinoid mechanisms and pharmacology are relevant to the current and future practice of clinical gastroenterology.” The study was published in the journal
A new study titled Systemic review of cannabis use and risk of occupational injury has found that adults who consume marijuana are no more likely to suffer injuries at work than are those employees who abstain from the substance. The study, conducted by researchers from the University of British Columbia, was published in the journal Substance Use and Misuse.